The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorShanghai Dermatology Hospital

About this trial

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Eligibility criteria

Qualifiers

Sensitive skin with a diagnosis of persistent erythema and a lactate irritation test score of 2-3

No related skin care products including bovine alkaline fibroblast growth factor were used within 1 month before participating in the experiment, and photoelectric treatment measures were not carried out

Physical sunscreen should be strict during enrollment

Disqualifiers

Children

Have serious heart, liver, kidney, and blood system diseases, and severe immunocompromise

Patients with mental illness or cancer

Those who have received glucocorticoids, calcineurin inhibitors, topical small molecule drugs, antibiotics or tretinoin within 3 months

Trial design

Treatments tested in this trial

  • bFGF
  • Bovine Basic Gel

Treatment groups

28 Participants
are divided into 2 treatment groups

Sponsors and collaborators